Categories: Patient Advocate, Patient Centricity, Patient Engagement, Strategy Alternative Facts on Social Media: Implications for Patient Education
Categories: Compassionate Use, Expanded Access, Policy, Pre-Approval Access, R&D, Strategy Trial Innovations: Potential Impact on Access to Experimental Treatments
Categories: Compassionate Use, Expanded Access, Policy, Pre-Approval Access, R&D, Strategy Pre-Approval Access Program Value Proposition
Categories: Innovation, Patient Advocate, Patient Centricity, Patient Engagement, Patient Journey Mapping, R&D Unprecedented Excitement about Advances in Lung Cancer Research at 2017 ASCO
Categories: Patient Advocate, Policy Protecting Patients’ Access to Health Insurance: Perspective from The National Coalition for Cancer Survivorship (NCCS)
Categories: Policy, Priority partners, R&D, Strategy Conflicts of Interest for Patient-Advocacy Organizations: Raising an Old Red Flag?
Categories: Innovation, Patient Advocate, Patient Centricity, Patient Engagement, R&D, Rare Disease Accelerating IBD Research Through Clinical Trial Participation
Categories: Expanded Access, Policy, Pre-Approval Access, Strategy, Uncategorized Expanded Access Expectations of the 21st Century Cures: Frequently Asked Questions
Categories: Innovation, Patient Centricity, Patient Engagement, Report, Strategy Building trust between patient groups and industry in troubled times: Report from ECRD
